A Scientific Interpretation of Stock and Clinical Trial Data that's easy to understand
Friday, March 09, 2007
Update: La Jolla Pharma still cruising
La Jolla pharma still rocking on today in late afternoon trading up up 41% [over $1.71 per share] to $5.84 on news of positive clinical data from it's Lupus drug Riquent. Rock on!
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.